U.S Class(es): 006, 018, 044, 046, 051, 052
Name | Novartis Pharma AG, |
---|---|
Address | Trademark Department Postfach CH-4002 Basel SWITZERLAND |
Date | Description | Action Tags | Code |
---|---|---|---|
May-29-2023 | TOTAL INVALIDATION PROCESSED BY THE IB | INNTP | |
May-09-2023 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | INTSP | |
May-09-2023 | INVALIDATION PROCESSED | INPCP | |
Mar-29-2023 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | INTRP | |
Jul-29-2022 | CANCELLED SECTION 71 | C71TO | |
Mar-04-2016 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Feb-18-2016 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
Feb-18-2016 | FINAL DISPOSITION PROCESSED | FIMPP | |
Feb-11-2016 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
Jan-12-2016 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
Oct-27-2015 | PUBLISHED FOR OPPOSITION | PUBOA | |
Oct-07-2015 | NOTICE OF PUBLICATION | NPUBO | |
Sep-20-2015 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
Sep-19-2015 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
Sep-16-2015 | ASSIGNED TO EXAMINER | DOCKD | |
Sep-15-2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Sep-14-2015 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
Sep-10-2015 | SN ASSIGNED FOR SECT 66A APPL FROM IB | REPRM |